Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Moderate sensorineural hearing loss is typical for DFNB16 caused by various types of mutations affecting the STRC gene

Z. Čada, D. Šafka Brožková, Z. Balatková, P. Plevová, D. Rašková, J. Laštůvková, R. Černý, V. Bandúrová, V. Koucký, S. Hrubá, M. Komarc, J. Jenčík, S. Poisson Marková, J. Plzák, J. Kluh, P. Seeman,

. 2019 ; 276 (12) : 3353-3358. [pub] 20190924

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc20005866

Grant support
16-31173A Ministerstvo Zdravotnictví Ceské Republiky
DRO 00064203 Ministerstvo Zdravotnictví Ceské Republiky
NV16-31173A MZ0 CEP Register

INTRODUCTION: Hearing loss is the most frequent sensory disorder and is genetically extremely heterogeneous. By far the most frequent cause of nonsyndromic autosomal recessive hearing loss (AR-NSHL) are biallelic pathogenic mutations in the GJB2 gene causing DFNB1. The worldwide search for the second most common type of AR-NSHL took almost two decades. Recently reported alterations (mostly deletions) of the STRC gene, also named DFNB16, seem to be the second most frequent cause of AR-NSHL. Genetic testing of STRC is very challenging due to the highly homologous pseudogene. Anecdotal evidence from single patients shows that STRC mutations have their typical audiological findings and patients usually have moderate hearing loss. The aim of this study is to discover if audiological findings in patients with biallelic pathogenic mutations affecting STRC have the characteristic features and shape of audiological curves and if there are genotype/phenotype correlations in relation to various types of STRC mutations. METHODS: Eleven hearing loss patients with pathogenic mutations on both alleles of the STRC gene were detected during routine genetic examination of AR-NSHL patients. Audiological examination consisted of pure tone audiometry, stapedial reflexes, tympanometry and otoacoustic emission tests. RESULTS: The threshold of pure tone average (PTA) was 46 dB and otoacoustic emissions were not detectable in these DFNB16 patients. All patients were without vestibular irritation or asymmetry. CONCLUSION: Moderate sensorineural hearing loss is typical for DFNB16-associated hearing loss and there are no significant differences in audiological phenotypes among different types of mutations affecting STRC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005866
003      
CZ-PrNML
005      
20200518132142.0
007      
ta
008      
200511s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00405-019-05649-5 $2 doi
035    __
$a (PubMed)31552524
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Čada, Zdeněk $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic. zdenek.cada@fnmotol.cz.
245    10
$a Moderate sensorineural hearing loss is typical for DFNB16 caused by various types of mutations affecting the STRC gene / $c Z. Čada, D. Šafka Brožková, Z. Balatková, P. Plevová, D. Rašková, J. Laštůvková, R. Černý, V. Bandúrová, V. Koucký, S. Hrubá, M. Komarc, J. Jenčík, S. Poisson Marková, J. Plzák, J. Kluh, P. Seeman,
520    9_
$a INTRODUCTION: Hearing loss is the most frequent sensory disorder and is genetically extremely heterogeneous. By far the most frequent cause of nonsyndromic autosomal recessive hearing loss (AR-NSHL) are biallelic pathogenic mutations in the GJB2 gene causing DFNB1. The worldwide search for the second most common type of AR-NSHL took almost two decades. Recently reported alterations (mostly deletions) of the STRC gene, also named DFNB16, seem to be the second most frequent cause of AR-NSHL. Genetic testing of STRC is very challenging due to the highly homologous pseudogene. Anecdotal evidence from single patients shows that STRC mutations have their typical audiological findings and patients usually have moderate hearing loss. The aim of this study is to discover if audiological findings in patients with biallelic pathogenic mutations affecting STRC have the characteristic features and shape of audiological curves and if there are genotype/phenotype correlations in relation to various types of STRC mutations. METHODS: Eleven hearing loss patients with pathogenic mutations on both alleles of the STRC gene were detected during routine genetic examination of AR-NSHL patients. Audiological examination consisted of pure tone audiometry, stapedial reflexes, tympanometry and otoacoustic emission tests. RESULTS: The threshold of pure tone average (PTA) was 46 dB and otoacoustic emissions were not detectable in these DFNB16 patients. All patients were without vestibular irritation or asymmetry. CONCLUSION: Moderate sensorineural hearing loss is typical for DFNB16-associated hearing loss and there are no significant differences in audiological phenotypes among different types of mutations affecting STRC.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a audiometrie $7 D001299
650    _2
$a dítě $7 D002648
650    _2
$a konexiny $x genetika $7 D017630
650    _2
$a hluchota $x genetika $7 D003638
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a percepční nedoslýchavost $x diagnóza $x genetika $7 D006319
650    _2
$a sluchové testy $7 D006320
650    _2
$a lidé $7 D006801
650    _2
$a mezibuněčné signální peptidy a proteiny $x genetika $7 D036341
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
650    _2
$a sekvenční delece $x genetika $7 D017384
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šafka Brožková, Dana $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Balatková, Zuzana $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Plevová, Pavlína $u Department of Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Rašková, Dagmar $u Centre for Medical Genetics and Reproductive Medicine, Gennet, Prague, Czech Republic.
700    1_
$a Laštůvková, Jana $u Department of Medical Genetics, Masaryk Hospital, Regional Health Corporation, Ústí nad Labem, Czech Republic.
700    1_
$a Černý, Rudolf $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Bandúrová, Veronika $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Koucký, Vladimír $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Hrubá, Silvie $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Komarc, Martin $u Department of Anthropomotorics and Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
700    1_
$a Jenčík, Ján $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Poisson Marková, Simona $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Plzák, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Kluh, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, Postgraduate Medical School, V Úvalu 84, Praha 5, 15006, Prague, Czech Republic.
700    1_
$a Seeman, Pavel $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
773    0_
$w MED00009617 $t European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery $x 1434-4726 $g Roč. 276, č. 12 (2019), s. 3353-3358
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31552524 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132141 $b ABA008
999    __
$a ok $b bmc $g 1524724 $s 1095922
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 276 $c 12 $d 3353-3358 $e 20190924 $i 1434-4726 $m European archives of oto-rhino-laryngology $n Eur Arch Otorhinolaryngol $x MED00009617
GRA    __
$a 16-31173A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a DRO 00064203 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NV16-31173A $p MZ0
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Archiving options